LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30139% above fair value
$14.08−0.07 (-0.49%)
Close on Nov 13, 2026Market cap $5.38BP/E 74.1Yield –
LifeStance Health price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
LifeStance Health's price to sales ratio was 3.5× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.2× to 5.7×, with a median of 2.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.5× | +1.5 |
| 2025 | Dec 31, 2025 | 2.0× | −0.3 |
| 2024 | Dec 31, 2024 | 2.3× | −0.6 |
| 2023 | Dec 29, 2023 | 3.0× | +0.7 |
| 2022 | Dec 30, 2022 | 2.3× | – |
See a number that looks wrong?